Phosphoramidites

2'-Modified Phosphoramidites
(529/529)
2'-Phosphoramidites
(27/27)
3'-Modified Phosphoramidites
(201/201)
5'-Modified Phosphoramidites
(30/30)
Arabino Phosphoramidites
(23/23)
Base Protected Phosphoramidites (418/418) Dye Phosphoramidites
(53/53)
Label Phosphoramidites
(82/82)
Linker Phosphoramidites
(81/81)
Other Phosphoramidites
(97/97)
PMO Phosphoramidates and Derivatives (33/33) PseudoUridine Phosphoramidite
(12/12)
Reverse Phosphoramidites
(25/25)
Spacer Phosphoramidites
(24/24)
Backbone
Modification
Base Type
Filtered by
Clear All

1-[(5E)-3-O-[(Bis-diisopropylamino)(2-cyanoethoxy)phosphino]-5,6-dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-β-D-ribohex-5-enofuranosyl]-N2-isobutyroylguanine

Description: 1-[(5E)-3-O-[(Bis-diisopropylamino)(2-cyanoethoxy)phosphino]-5,6-dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-β-D-ribohex-5-enofuranosyl]-N2-isobutyroylguanine is a modified phosphoramidite compound used in oligonucleotides synthesis. This compound is primarily used in the solid-phase synthesis of RNA, where the protecting groups ensure that selective reactions occur at the desired sites. The phosphoramidite functionality facilitates the stepwise addition of nucleotides during automated oligonucleotide synthesis, allowing for the controlled assembly of RNA sequences.
CAT: BRP-02475
Molecular Formula: C29H47N7O9P2
Molecular Weight: 699.68
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: BLZYIQYIBDZHTR-GXTDANTHSA-N
CanonicalSMILES: CO[C@@H]1[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](/C=C/P(OCC)(OCC)=O)O[C@H]1N2C(N=C(NC(C(C)C)=O)NC3=O)=C3N=C2
IUPAC Name: 2-cyanoethyl ((2R,3R,4R,5R)-2-((E)-2-(diethoxyphosphoryl)vinyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl) diisopropylphosphoramidite
InChI: InChI=1S/C29H47N7O9P2/c1-10-42-47(39,43-11-2)16-13-21-23(45-46(41-15-12-14-30)36(19(5)6)20(7)8)24(40-9)28(44-21)35-17-31-22-25(35)32-29(34-27(22)38)33-26(37)18(3)4/h13,16-21,23-24,28H,10-12,15H2,1-9H3,(H2,32,33,34,37,38)/b16-13+/t21-,23-,24-,28-,46?/m1/s1
Synonyms: 5'-Et-(E)-vinyl phosphonate-2'-O-Me-rG(iBu)-3'-CE-Phosphoramidite; 5'-Ethyl-(E)-vinyl phosphonate-2'-O-Me-rG(iBu)-3'-CE-Phosphoramidite; 1-[(5E)-3-O-[(Bis-diisopropylmino)(2-cyanoethoxy)phosphino]-5,6-dideoxy-6-(dimethoxyphosphinyl)-2-O-methyl-β-D-ribohex-5-enofuranosyl]-N2-isobutyroylguanine

1-[(5E)-3-O-[(Bis-diisopropylamino)(2-cyanoethoxy)phosphino]-5,6-dideoxy-6-(diethoxyphosphinyl)-2-O-(2-MOE)-β-D-ribo-hex-5-enofuranosyl]uracil

Description: 1-[(5E)-3-O-[(Bis-diisopropylamino)(2-cyanoethoxy)phosphino]-5,6-dideoxy-6-(diethoxyphosphinyl)-2-O-(2-MOE)-β-D-ribo-hex-5-enofuranosyl]uracil is a modified phosphoramidite compound used in oligonucleotides synthesis. This compound is primarily used in the solid-phase synthesis of RNA, where the protecting groups ensure that selective reactions occur at the desired sites. The phosphoramidite functionality facilitates the stepwise addition of nucleotides during automated oligonucleotide synthesis, allowing for the controlled assembly of RNA sequences.
CAT: BRP-02476
Molecular Formula: C26H44N4O10P2
Molecular Weight: 634.60
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: ZYDXGMNXIGPASP-PEZPBANCSA-N
CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)O[C@H]1[C@@H](OCCOC)[C@H](N2C(NC(C=C2)=O)=O)O[C@@H]1/C=C/P(OCC)(OCC)=O
IUPAC Name: 2-cyanoethyl ((2R,3R,4R,5R)-2-((E)-2-(diethoxyphosphoryl)vinyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl) diisopropylphosphoramidite
InChI: InChI=1S/C26H44N4O10P2/c1-8-37-42(33,38-9-2)18-12-21-23(40-41(36-15-10-13-27)30(19(3)4)20(5)6)24(35-17-16-34-7)25(39-21)29-14-11-22(31)28-26(29)32/h11-12,14,18-21,23-25H,8-10,15-17H2,1-7H3,(H,28,31,32)/b18-12+/t21-,23-,24-,25-,41?/m1/s1
Synonyms: 5'-Et-(E)-vinyl phosphonate-2'-O-MOE-rU-3'-CE-Phosphoramidite; 5'-Ethyl-(E)-vinyl phosphonate-2'-O-MOE-rU-3'-CE-Phosphoramidite; 1-[(5E)-3-O-[(Bis-diisopropylamino)(2-cyanoethoxy)phosphino]-5,6-dideoxy-6-(diethoxyphosphinyl)-2-O-(2-methoxyethyl)-β-D-ribo-hex-5-enofuranosyl]uracil

5'-O-DMTr-2'-O-Trifluoroacetamindo propyl-C(Ac)-3'-CE-Phosphoramidite

Description: 5'-O-DMTr-2'-O-Trifluoroacetamindo propyl-C(Ac)-3'-CE-Phosphoramidite is a highly modified cytidine phosphoramidite used in oligonucleotide synthesis. The 5'-O-DMTr (dimethoxytrityl) group serves as a protective group for the 5' hydroxyl during stepwise synthesis. The 2'-O-trifluoroacetamindo propyl modification adds a trifluoroacetamido group linked via a propyl spacer to the 2'-hydroxyl of the ribose, enhancing hydrophobicity and potentially altering enzymatic interactions or duplex stability. The C(Ac) designation indicates that the cytosine base is protected by an acetyl group at the N4 position, ensuring stability during synthesis. The 3'-CE phosphoramidite (cyanoethyl) group enables the coupling of this nucleotide into a growing oligonucleotide chain via phosphoramidite chemistry. This compound is often employed in the synthesis of modified oligonucleotides for research or therapeutic purposes, where specific modifications are required for stability, resistance to degradation, or unique biological functionality.
CAT: BRP-02480
Molecular Formula: C46H56F3N6O10P
Molecular Weight: 940.95
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: CVNXSPGCWPGLBY-CHKGVOQCSA-N
CanonicalSMILES: COC(C=C1)=CC=C1C(C2=CC=C(OC)C=C2)(C3=CC=CC=C3)OC[C@H]4O[C@@H](N5C(N=C(NC(C)=O)C=C5)=O)[C@H](OCCCNC(C(F)(F)F)=O)[C@@H]4OP(OCCC#N)N(C(C)C)C(C)C
IUPAC Name: (2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(3-(2,2,2-trifluoroacetamido)propoxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C46H56F3N6O10P/c1-30(2)55(31(3)4)66(63-28-11-24-50)65-40-38(64-42(54-26-23-39(52-32(5)56)53-44(54)58)41(40)61-27-12-25-51-43(57)46(47,48)49)29-62-45(33-13-9-8-10-14-33,34-15-19-36(59-6)20-16-34)35-17-21-37(60-7)22-18-35/h8-10,13-23,26,30-31,38,40-42H,11-12,25,27-29H2,1-7H3,(H,51,57)(H,52,53,56,58)/t38-,40-,41-,42-,66?/m1/s1
Synonyms: N4-Acetyl-5'-O-(4,4'-Dimethoxytrityl)-2'-O-trifluoroacetamido propyl-cytidine-3'-[(2-cyanoethyl)-(N,N-diisopropropyl)]-Phosphoramidite; N4-Acetyl-5'-O-DMTr-2'-O-(N3-trifluoroacetyl)cytidine 3'-CE-Phosphoramidite; Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[3-[(trifluoroacetyl)amino]propyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]; N4-Acetyl-2'-O-trifluoroacetamido propyl Cytidine CED phosphoramidite

5'-O-DMTr-5-trifluoroacetylaminomethyl-2'-O-TBDMS uridine 3'-CED phosphoramidite

Description: 5'-O-DMTr-5-trifluoroacetylaminomethyl-2'-O-TBDMS uridine 3'-CED phosphoramidite is a chemically modified phosphoramidite designed for oligonucleotide synthesis. Its structure features a 5'-dimethoxytrityl (DMTr) group for temporary protection during solid-phase synthesis, a 5-position trifluoroacetylaminomethyl group to introduce functionalized side chains, a 2'-O-tert-butyldimethylsilyl (TBDMS) group for ribose protection, and a 3'-cyanoethyl diisopropyl phosphoramidite for coupling. This compound is used in the synthesis of RNA oligonucleotides, enabling the incorporation of modified residues for structural, therapeutic, or biochemical applications, such as enhancing stability or introducing specific reactive functionalities.
CAT: BRP-02487
Molecular Formula: C48H63F3N5O10PSi
Molecular Weight: 986.11
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: YWHOOIBNERVNIX-KMXDGGROSA-N
CanonicalSMILES: COC(C=C1)=CC=C1C(C2=CC=C(OC)C=C2)(C3=CC=CC=C3)OC[C@H]4O[C@@H](N(C=C(CNC(C(F)(F)F)=O)C5=O)C(N5)=O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]4OP(N(C(C)C)C(C)C)OCCC#N
IUPAC Name: (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(2,4-dioxo-5-((2,2,2-trifluoroacetamido)methyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C48H63F3N5O10PSi/c1-31(2)56(32(3)4)67(63-27-15-26-52)65-40-39(30-62-47(34-16-13-12-14-17-34,35-18-22-37(60-8)23-19-35)36-20-24-38(61-9)25-21-36)64-43(41(40)66-68(10,11)46(5,6)7)55-29-33(42(57)54-45(55)59)28-53-44(58)48(49,50)51/h12-14,16-25,29,31-32,39-41,43H,15,27-28,30H2,1-11H3,(H,53,58)(H,54,57,59)/t39-,40-,41-,43-,67?/m1/s1
Synonyms: DMTr-2'-O-TBDMS-5-trifluoroacetylaminomethyl-rU-3'-CE-Phosphoramidite; 5'-DMT-2'-O-TBDMS-5-trifluoroacetylaminomethyl-rU Phosphoramidite; DMT-2'-O-TBDMS-5-trifluoroacetylaminomethyl-rU Phosphoramidite; 5'-O-(4,4-Dimethoxytrityl)-5-trifluoroacetylaminomethyl-2'-O-[(tert-butyl)dimethylsilyl]uridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite; 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-5-trifluoroacetylaminomethyl-uridine 3'-CE phosphoramidite; 5'-O-(4,4'-Dimethoxytrityl)-2'-O-(t-butyl-dimethylsilyl)-5-trifluoroacetylaminomethyl-uridine-3'-cyanoethyl Phosphoramidite

5'-O-DMTr-2'-O-(N-tri-fluoroacetylamino)ethyl-5-methyluridine 3'-CE-phosphoramidite

Description: 5'-O-DMTr-2'-O-(N-tri-fluoroacetylamino)ethyl-5-methyluridine 3'-CE-phosphoramidite is a modified phosphoramidite designed for oligonucleotide synthesis. The structure includes a 5-methyluridine base with a 2'-O-(N-tri-fluoroacetylamino)ethyl modification on the ribose, which enhances the molecule's stability and may influence its interaction with biological systems. The 5'-hydroxyl group is protected with a dimethoxytrityl (DMTr) group for efficient coupling during solid-phase synthesis, while the 3'-hydroxyl is protected with a cyanoethyl (CE) phosphoramidite group for coupling in the synthesis process. This modification improves the stability and specificity of the resulting oligonucleotides, making it suitable for use in RNA-based applications, including therapeutic and diagnostic purposes.
CAT: BRP-02490
CAS: 200423-98-9
Molecular Formula: C44H53F3N5O10P
Molecular Weight: 899.89
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: KYHISSPNOZNEDF-AHGBXEAISA-N
CanonicalSMILES: N#CCCOP(OC1C(OC(N2C=C(C(=O)NC2=O)C)C1OCCNC(=O)C(F)(F)F)COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)N(C(C)C)C(C)C
IUPAC Name: (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-(2-(2,2,2-trifluoroacetamido)ethoxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C44H53F3N5O10P/c1-28(2)52(29(3)4)63(60-24-11-22-48)62-37-36(61-40(51-26-30(5)39(53)50-42(51)55)38(37)58-25-23-49-41(54)44(45,46)47)27-59-43(31-12-9-8-10-13-31,32-14-18-34(56-6)19-15-32)33-16-20-35(57-7)21-17-33/h8-10,12-21,26,28-29,36-38,40H,11,23-25,27H2,1-7H3,(H,49,54)(H,50,53,55)/t36-,37-,38-,40-,63?/m1/s1
Synonyms: 2'-O-Amino linker-5-methyl U CEP; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-5-methyl-2'-O-[2-[(trifluoroacetyl)amino]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]; 5'-O-DMTr-2'-O-(N-tri-fluoroacetylamino)ethyl-5-MeU-3'-CE-Phosphoramidite; 5'-O-(4,4'-Dimethoxytrityl)-2'-O-(N-tri-fluoroacetylamino)ethyl-5-methyluridine-3'-[(2-cyanoethyl)-(N,N-diisopropropyl)]-Phosphoramidite; 2'-TFA-AE T amidite

Dimethyl P-[[[(2R,3S,4R,5R)-3-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]-5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)tetrahydro-4-methoxy-2-furanyl]oxy]methyl]phosphonate

Description: It is a modified phosphoramidite designed for medicinal chemistry purposes, likely targeting specific enzymes or pathways in nucleotide metabolism, cell signaling, or as a potential therapeutic agent for diseases where phosphorothioate or phosphonate derivatives play a key role in inhibition or modulation.
CAT: BRP-02493
CAS: 2197181-94-3
Molecular Formula: C21H36N4O10P2
Molecular Weight: 566.48
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: CAAOTZQHIFLMLL-DPNUVZDTSA-N
CanonicalSMILES: N#CCCOP(OC1C(OCP(=O)(OC)OC)OC(N2C=CC(=O)NC2=O)C1OC)N(C(C)C)C(C)C
IUPAC Name: 2-cyanoethyl ((2R,3S,4R,5R)-2-((dimethoxyphosphoryl)methoxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl) diisopropylphosphoramidite
InChI: InChI=1S/C21H36N4O10P2/c1-14(2)25(15(3)4)36(33-12-8-10-22)35-18-17(29-5)19(24-11-9-16(26)23-21(24)27)34-20(18)32-13-37(28,30-6)31-7/h9,11,14-15,17-20H,8,12-13H2,1-7H3,(H,23,26,27)/t17-,18+,19-,20+,36?/m1/s1
Synonyms: MeMOP; Phosphonic acid, P-[[[(2R,3S,4R,5R)-3-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]-5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)tetrahydro-4-methoxy-2-furanyl]oxy]methyl]-, dimethyl ester

1-O-(4,4'-Dimethoxytrityl)-3-O-succinyl-1,3-propanediol

Description: 1-O-(4,4'-Dimethoxytrityl)-3-O-succinyl-1,3-propanediol is a bifunctional molecule commonly used as a linker or spacer in the synthesis of oligonucleotides. The 1-hydroxyl group is protected with a 4,4'-dimethoxytrityl (DMT) group, which serves as a temporary protecting group during solid-phase synthesis, enabling stepwise addition of nucleotides. The 3-hydroxyl group is modified with a succinyl moiety, introducing a carboxylic acid functionality that allows covalent attachment to solid supports, such as controlled-pore glass (CPG) or polymers. This compound is critical in oligonucleotide synthesis, ensuring efficient attachment and controlled chain elongation during automated synthesis processes.
CAT: BRP-02496
CAS: 110916-49-9
Molecular Formula: C28H30O7
Molecular Weight: 478.53
Purity: ≥97%
Appearance: White or off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at RT
Density: 1.193±0.06 g/cm3
Boiling Point: 638.6±55.0 °C at 760 mmHg
InChIKey: FDXRQUXDYAHNQG-UHFFFAOYSA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCCCOC(=O)CCC(=O)O
IUPAC Name: 4-[3-[bis(4-methoxyphenyl)-phenylmethoxy]propoxy]-4-oxobutanoic acid
InChI: InChI=1S/C28H30O7/c1-32-24-13-9-22(10-14-24)28(21-7-4-3-5-8-21,23-11-15-25(33-2)16-12-23)35-20-6-19-34-27(31)18-17-26(29)30/h3-5,7-16H,6,17-20H2,1-2H3,(H,29,30)
Synonyms: Butanedioic acid, 1-[3-[bis(4-methoxyphenyl)phenylmethoxy]propyl] ester; 1-[3-[Bis(4-methoxyphenyl)phenylmethoxy]propyl] butanedioate; Butanedioic acid, mono[3-[bis(4-methoxyphenyl)phenylmethoxy]propyl] ester
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket